Celeste C Finnerty1, Arham Ali2, Josef McLean2, Nicole Benjamin2, Robert P Clayton2, Clark R Andersen2, Ronald P Mlcak3, Oscar E Suman2, Walter Meyer3, David N Herndon2. 1. Shriners Hospitals for Children-Galveston, University of Texas Medical Branch, Galveston, TX; Department of Surgery, University of Texas Medical Branch, Galveston, TX; Institute for Translational Sciences, University of Texas Medical Branch, Galveston, TX; Sealy Center for Molecular Medicine, University of Texas Medical Branch, Galveston, TX. Electronic address: ccfinner@utmb.edu. 2. Shriners Hospitals for Children-Galveston, University of Texas Medical Branch, Galveston, TX; Department of Surgery, University of Texas Medical Branch, Galveston, TX. 3. Shriners Hospitals for Children-Galveston, University of Texas Medical Branch, Galveston, TX.
Abstract
BACKGROUND: Post-burn hyperglycemia leads to graft failure, multiple organ failure, and death. A hyperinsulinemic-euglycemic clamp is used to keep serum glucose between 60 and 110 mg/dL. Because of frequent hypoglycemic episodes, a less-stringent sliding scale insulin protocol is used to maintain serum glucose levels between 80 and 160 mg/dL after elevations >180 mg/dL. STUDY DESIGN: We randomized pediatric patients with massive burns into 2 groups, patients receiving sliding scale insulin to lower blood glucose levels (n = 145) and those receiving no insulin (n = 98), to determine the differences in morbidity and mortality. Patients 0 to 18 years old with burns covering ≥ 30% of the total body surface area and not randomized to receiveanabolic agents were included in this study. End points included glucose levels, infections, resting energy expenditure, lean body mass, bone mineral content, fat mass, muscle strength, and serum inflammatory cytokines, hormones, and liver enzymes. RESULTS:Maximal glucose levels occurred within 6 days of burn injury. Blood glucose levels were age dependent, with older children requiring more insulin (p < 0.05). Daily maximum and daily minimum, but not 6 am, glucose levels were significantly different based on treatment group (p < 0.05). Insulin significantly increased resting energy expenditure and improved bone mineral content (p < 0.05). Each additional wound infection increased incidence of hyperglycemia (p = 0.004). There was no mortality in patients not receiving insulin, only in patients who received insulin (p < 0.004). Muscle strength was increased in patients receiving insulin (p < 0.05). CONCLUSIONS: Burn-induced hyperglycemia develops in a subset of severely burned children. Length of stay was reduced in the no insulin group, and there were no deaths in this group. Administration of insulin positively impacted bone mineral content and muscle strength, but increased resting energy expenditure, hypoglycemic episodes, and mortality. New glucose-lowering strategies might be needed.
RCT Entities:
BACKGROUND: Post-burn hyperglycemia leads to graft failure, multiple organ failure, and death. A hyperinsulinemic-euglycemic clamp is used to keep serum glucose between 60 and 110 mg/dL. Because of frequent hypoglycemic episodes, a less-stringent sliding scale insulin protocol is used to maintain serum glucose levels between 80 and 160 mg/dL after elevations >180 mg/dL. STUDY DESIGN: We randomized pediatric patients with massive burns into 2 groups, patients receiving sliding scale insulin to lower blood glucose levels (n = 145) and those receiving no insulin (n = 98), to determine the differences in morbidity and mortality. Patients 0 to 18 years old with burns covering ≥ 30% of the total body surface area and not randomized to receive anabolic agents were included in this study. End points included glucose levels, infections, resting energy expenditure, lean body mass, bone mineral content, fat mass, muscle strength, and serum inflammatory cytokines, hormones, and liver enzymes. RESULTS: Maximal glucose levels occurred within 6 days of burn injury. Blood glucose levels were age dependent, with older children requiring more insulin (p < 0.05). Daily maximum and daily minimum, but not 6 am, glucose levels were significantly different based on treatment group (p < 0.05). Insulin significantly increased resting energy expenditure and improved bone mineral content (p < 0.05). Each additional wound infection increased incidence of hyperglycemia (p = 0.004). There was no mortality in patients not receiving insulin, only in patients who received insulin (p < 0.004). Muscle strength was increased in patients receiving insulin (p < 0.05). CONCLUSIONS: Burn-induced hyperglycemia develops in a subset of severely burned children. Length of stay was reduced in the no insulin group, and there were no deaths in this group. Administration of insulin positively impacted bone mineral content and muscle strength, but increased resting energy expenditure, hypoglycemic episodes, and mortality. New glucose-lowering strategies might be needed.
Authors: David W Hart; Steven E Wolf; David N Herndon; David L Chinkes; Sophia O Lal; Michael K Obeng; Robert B Beauford; Ronald P Mlcak RT Journal: Ann Surg Date: 2002-01 Impact factor: 12.969
Authors: Celeste C Finnerty; David N Herndon; Rene Przkora; Clifford T Pereira; Hermes M Oliveira; Dulciene M M Queiroz; Andreia M C Rocha; Marc G Jeschke Journal: Shock Date: 2006-07 Impact factor: 3.454
Authors: Dirk Vlasselaers; Ilse Milants; Lars Desmet; Pieter J Wouters; Ilse Vanhorebeek; Ingeborg van den Heuvel; Dieter Mesotten; Michael P Casaer; Geert Meyfroidt; Catherine Ingels; Jan Muller; Sophie Van Cromphaut; Miet Schetz; Greet Van den Berghe Journal: Lancet Date: 2009-01-26 Impact factor: 79.321
Authors: Dennis C Gore; David L Chinkes; David W Hart; Steven E Wolf; David N Herndon; Arthur P Sanford Journal: Crit Care Med Date: 2002-11 Impact factor: 7.598
Authors: Gerd G Gauglitz; David N Herndon; Gabriela A Kulp; Walter J Meyer; Marc G Jeschke Journal: J Clin Endocrinol Metab Date: 2009-02-24 Impact factor: 5.958
Authors: David N Herndon; Charles D Voigt; Karel D Capek; Paul Wurzer; Ashley Guillory; Andrea Kline; Clark R Andersen; Gordon L Klein; Ronald G Tompkins; Oscar E Suman; Celeste C Finnerty; Walter J Meyer; Linda E Sousse Journal: Ann Surg Date: 2016-09 Impact factor: 12.969
Authors: Christopher S Fry; Craig Porter; Labros S Sidossis; Christopher Nieten; Paul T Reidy; Gabriel Hundeshagen; Ronald Mlcak; Blake B Rasmussen; Jong O Lee; Oscar E Suman; David N Herndon; Celeste C Finnerty Journal: J Physiol Date: 2016-07-15 Impact factor: 5.182
Authors: Jill M Bayliss; Benjamin Levi; Jianfeng Wu; Stewart C Wang; Grace L Su; Chuanwu Xi Journal: J Burn Care Res Date: 2016 Nov/Dec Impact factor: 1.845
Authors: Celeste C Finnerty; Karel D Capek; Charles Voigt; Gabriel Hundeshagen; Janos Cambiaso-Daniel; Craig Porter; Linda E Sousse; Amina El Ayadi; Ramon Zapata-Sirvent; Ashley N Guillory; Oscar E Suman; David N Herndon Journal: J Trauma Acute Care Surg Date: 2017-09 Impact factor: 3.313
Authors: Karel D Capek; Linda E Sousse; Gabriel Hundeshagen; Charles D Voigt; Oscar E Suman; Celeste C Finnerty; Kristofer Jennings; David N Herndon Journal: J Am Coll Surg Date: 2018-03-09 Impact factor: 6.113
Authors: Larissa C Hermeto; Rafael DeRossi; Rodrigo J Oliveira; Felipe G Gomes; Wallison R Ferreira; Juliana A Galhardo; Tessie Bm Möck; William Vs Basaglia; Diogo M Fernandes Journal: Int J Burns Trauma Date: 2020-12-15
Authors: Robert Kraft; David N Herndon; Celeste C Finnerty; Robert A Cox; Juquan Song; Marc G Jeschke Journal: Shock Date: 2015-03 Impact factor: 3.454
Authors: David Herndon; Karel D Capek; Evan Ross; Jayson W Jay; Anesh Prasai; Amina El Ayadi; Guillermo Foncerrada-Ortega; Elizabeth Blears; Christian Sommerhalder; Kara McMullen; Dagmar Amtmann; Robert Cox; Gabriel Hundeshagen; Kristofer Jennings; Linda E Sousse; Oscar E Suman; Walter J Meyer; Celeste C Finnerty Journal: Ann Surg Date: 2018-09 Impact factor: 12.969